International Clinical Trial: Efficacy and Safety of Tegileridine for Postoperative Analgesia Following Uvulopalatopharyngoplasty

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132706) titled 'Efficacy and Safety of Tegileridine for Postoperative Analgesia Following Uvulopalatopharyngoplasty' on Sept. 17.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Linyi People's Hospital

Condition: Obstructive sleep apnea

Intervention: Sufentanil Analgesia Group:100 µg of sufentanil, diluted with saline to 100 mL initial loading dose of 3 µg PCA dose of 2 µg (2 mL) lockout time of 10 minutes. Tegileridine Analgesia Group:Tegilidine 5 mg, diluted with normal saline to 100 mL initial loading dose of 0.75 mg PCA dose of 0.05 mg (1 mL)

Recruitment Status: Not Recruiting...